1-169376656-A-C
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 4P and 4B. PM1PM2BP4_Strong
The NM_001320973.2(BLZF1):āc.145A>Cā(p.Ser49Arg) variant causes a missense change. The variant allele was found at a frequency of 0.000621 in 1,613,392 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.00033 ( 1 hom., cov: 32)
Exomes š: 0.00065 ( 0 hom. )
Consequence
BLZF1
NM_001320973.2 missense
NM_001320973.2 missense
Scores
1
4
14
Clinical Significance
Conservation
PhyloP100: 6.54
Genes affected
BLZF1 (HGNC:1065): (basic leucine zipper nuclear factor 1) Enables ubiquitin protein ligase binding activity. Acts upstream of or within Golgi organization and Golgi to plasma membrane protein transport. Located in Golgi apparatus and nucleoplasm. Biomarker of hepatocellular carcinoma. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 0 ACMG points.
PM1
In a modified_residue Phosphoserine (size 0) in uniprot entity GO45_HUMAN
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.056455076).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
BLZF1 | NM_001320973.2 | c.145A>C | p.Ser49Arg | missense_variant | 3/7 | ENST00000367808.8 | |
BLZF1 | NM_003666.4 | c.145A>C | p.Ser49Arg | missense_variant | 3/8 | ||
BLZF1 | NM_001320972.2 | c.145A>C | p.Ser49Arg | missense_variant | 3/3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
BLZF1 | ENST00000367808.8 | c.145A>C | p.Ser49Arg | missense_variant | 3/7 | 1 | NM_001320973.2 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000329 AC: 50AN: 152040Hom.: 1 Cov.: 32
GnomAD3 genomes
AF:
AC:
50
AN:
152040
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000431 AC: 108AN: 250722Hom.: 0 AF XY: 0.000413 AC XY: 56AN XY: 135518
GnomAD3 exomes
AF:
AC:
108
AN:
250722
Hom.:
AF XY:
AC XY:
56
AN XY:
135518
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000652 AC: 952AN: 1461234Hom.: 0 Cov.: 31 AF XY: 0.000600 AC XY: 436AN XY: 726950
GnomAD4 exome
AF:
AC:
952
AN:
1461234
Hom.:
Cov.:
31
AF XY:
AC XY:
436
AN XY:
726950
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000329 AC: 50AN: 152158Hom.: 1 Cov.: 32 AF XY: 0.000255 AC XY: 19AN XY: 74394
GnomAD4 genome
AF:
AC:
50
AN:
152158
Hom.:
Cov.:
32
AF XY:
AC XY:
19
AN XY:
74394
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
5
ALSPAC
AF:
AC:
7
ESP6500AA
AF:
AC:
3
ESP6500EA
AF:
AC:
6
ExAC
AF:
AC:
69
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 21, 2023 | The c.145A>C (p.S49R) alteration is located in exon 3 (coding exon 2) of the BLZF1 gene. This alteration results from a A to C substitution at nucleotide position 145, causing the serine (S) at amino acid position 49 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
DEOGEN2
Benign
.;T;T;T;T
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Pathogenic
D
LIST_S2
Benign
T;T;.;T;T
M_CAP
Benign
D
MetaRNN
Benign
T;T;T;T;T
MetaSVM
Benign
T
MutationAssessor
Uncertain
M;M;M;.;.
MutationTaster
Benign
D;D;D
PrimateAI
Benign
T
PROVEAN
Uncertain
D;N;N;D;N
REVEL
Benign
Sift
Uncertain
D;D;D;D;D
Sift4G
Benign
T;T;T;T;T
Polyphen
D;B;B;.;.
Vest4
MutPred
Gain of solvent accessibility (P = 0.0023);Gain of solvent accessibility (P = 0.0023);Gain of solvent accessibility (P = 0.0023);Gain of solvent accessibility (P = 0.0023);Gain of solvent accessibility (P = 0.0023);
MVP
MPC
0.15
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at